Canaccord Genuity Maintains Buy on Compass Pathways, Lowers Price Target to $48
COMPASS Pathways plc +0.28%
COMPASS Pathways plc CMPS | 7.22 | +0.28% |
Canaccord Genuity analyst Sumant Kulkarni maintains Compass Pathways (NASDAQ:
CMPS) with a Buy and lowers the price target from $50 to $48.